Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches
- PMID: 35955491
- PMCID: PMC9369148
- DOI: 10.3390/ijms23158361
Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches
Abstract
Crohn's disease (CD) is a complex, disabling, idiopathic, progressive, and destructive disorder with an unknown etiology. The pathogenesis of CD is multifactorial and involves the interplay between host genetics, and environmental factors, resulting in an aberrant immune response leading to intestinal inflammation. Due to the high morbidity and long-term management of CD, the development of non-pharmacological approaches to mitigate the severity of CD has recently attracted great attention. The gut microbiota has been recognized as an important player in the development of CD, and general alterations in the gut microbiome have been established in these patients. Thus, the gut microbiome has emerged as a pre-eminent target for potential new treatments in CD. Epidemiological and interventional studies have demonstrated that diet could impact the gut microbiome in terms of composition and functionality. However, how specific dietary strategies could modulate the gut microbiota composition and how this would impact host-microbe interactions in CD are still unclear. In this review, we discuss the most recent knowledge on host-microbe interactions and their involvement in CD pathogenesis and severity, and we highlight the most up-to-date information on gut microbiota modulation through nutritional strategies, focusing on the role of the microbiota in gut inflammation and immunity.
Keywords: Crohn’s disease; diet; gut microbiome; immunonutrition; inflammation.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Role and mechanism of gut microbiota-host interactions in the pathogenesis of Crohn's disease.Int J Colorectal Dis. 2025 May 28;40(1):130. doi: 10.1007/s00384-025-04917-7. Int J Colorectal Dis. 2025. PMID: 40437310 Free PMC article. Review.
-
Exploring gut microbiota as a novel therapeutic target in Crohn's disease: Insights and emerging strategies.World J Gastroenterol. 2025 Jan 14;31(2):100827. doi: 10.3748/wjg.v31.i2.100827. World J Gastroenterol. 2025. PMID: 39811502 Free PMC article. Review.
-
The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.Gastroenterol Clin North Am. 2017 Sep;46(3):481-492. doi: 10.1016/j.gtc.2017.05.004. Epub 2017 Jul 19. Gastroenterol Clin North Am. 2017. PMID: 28838410 Review.
-
Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn's disease.J Transl Med. 2024 May 30;22(1):518. doi: 10.1186/s12967-024-05317-1. J Transl Med. 2024. PMID: 38816750 Free PMC article.
-
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.Gastroenterology. 2022 Sep;163(3):685-698. doi: 10.1053/j.gastro.2022.05.037. Epub 2022 May 26. Gastroenterology. 2022. PMID: 35643175
Cited by
-
Metaproteomics reveals diet-induced changes in gut microbiome function according to Crohn's disease location.Microbiome. 2024 Oct 23;12(1):217. doi: 10.1186/s40168-024-01927-5. Microbiome. 2024. PMID: 39443987 Free PMC article.
-
Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches.Int J Mol Sci. 2024 Sep 8;25(17):9715. doi: 10.3390/ijms25179715. Int J Mol Sci. 2024. PMID: 39273662 Free PMC article. Review.
-
Mixed-method Irish study exploring the role of diet in IBD based on an online questionnaire and a patient panel opinion.BMJ Open Gastroenterol. 2024 Oct 29;11(1):e001251. doi: 10.1136/bmjgast-2023-001251. BMJ Open Gastroenterol. 2024. PMID: 39477248 Free PMC article.
-
Advances in gut microbiota functions in inflammatory bowel disease: Dysbiosis, management, cytotoxicity assessment, and therapeutic perspectives.Comput Struct Biotechnol J. 2025 Feb 25;27:851-868. doi: 10.1016/j.csbj.2025.02.026. eCollection 2025. Comput Struct Biotechnol J. 2025. PMID: 40115534 Free PMC article. Review.
-
Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions.Nutrients. 2025 May 30;17(11):1879. doi: 10.3390/nu17111879. Nutrients. 2025. PMID: 40507145 Free PMC article. Review.
References
-
- Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., Panaccione R., Ghosh S., Wu J.C.Y., Chan F.K.L., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390:2769–2778. doi: 10.1016/S0140-6736(17)32448-0. - DOI - PubMed
-
- Wilkins T., Jarvis K., Patel J. Diagnosis and management of Crohn’s disease. Am. Fam. Phys. 2011;84:1365–1375. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical